HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (3- pentylamino)- 2,7- dimethyl- 8- (2- methyl- 4- methoxyphenyl)pyrazolo(1,5- a)pyrimidine

an hCRF(1) antagonist; structure in first source

Also Known As:

4-(3-pentylamino)-DMMPP; DMP-904; DMP904

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)pyrazolo(1,5-a)pyrimidine: 1
  - Pyrimidines: 510
    - 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)pyrazolo(1,5-a)pyrimidine: 1

Experts

1.	Arneric, Stephen P: 1 article (04/2004)
2.	Gilligan, Paul J: 1 article (04/2004)
3.	Godonis, Helen E: 1 article (04/2004)
4.	Grossman, Scott: 1 article (04/2004)
5.	Hartig, Paul R: 1 article (04/2004)
6.	Heman, Karen L: 1 article (04/2004)
7.	Lelas, Snjezana: 1 article (04/2004)
8.	Li, Yu-Wen: 1 article (04/2004)
9.	McElroy, John F: 1 article (04/2004)
10.	Polino, Joseph L: 1 article (04/2004)

Related Diseases

1.	Ataxia (Dyssynergia) 04/01/2004 - "Unlike alprazolam, DMP904 did not produce sedation, ataxia, or chlordiazepoxide-like subjective effects (as measured by locomotor activity, rotorod performance, and chlordiazepoxide discrimination assays, respectively) at doses at least 3-fold higher than anxiolytic-like doses. "

Related Drugs and Biologics

1.	Anti-Anxiety Agents (Anxiolytics)
2.	Chlordiazepoxide (Elenium)
3.	Alprazolam (Xanax)